SOCS1 and metabolic dysfunction-associated steatotic liver disease: Reports by Chen et al. showed that treatment with UDCA negatively regulates SOCS1 expression, down-regulates STAT phosphorylation, promotes macrophage polarization toward the M2 type, and ameliorates the effects of liver injury in NAFLD mice [59].